The United States military and Leishmaniasis

Dermatologic Clinics

Volumn 17, Issue 1, 1999, Pages 77-92

  Kenner, J R ^a   Aronson, N E ^a   Benson, P M ^a  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; MEGLUMINE ANTIMONATE; PENTAMIDINE; STIBOGLUCONATE SODIUM;

ARTHRALGIA; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DOSE RESPONSE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LEISHMANIASIS; LIFE CYCLE; MILITARY MEDICINE; NEPHROTOXICITY; PANCREATITIS; PARASITE TRANSMISSION; PATHOGENESIS; PRIORITY JOURNAL; SERODIAGNOSIS; SKIN TEST; UNITED STATES;

EID: 0032944769     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70071-1     Document Type: Article

References (101)

1. Abalos FM, Klassen MK, Marty AM, et al: Brown-Hopps stain for Leishmania amastigotes. Abstract, International Academy of Pathology Meeting, Boston, MA, 1997
2. J. Alvar C. Canavate B. Gutierriz-Solar Leishmania and HIV co-infection: The first 10 years Clin Microbiol Rev 10 2 1997 298
3. C.R. Alving E.A. Steck W.L. Chapman Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs Proc Natl Acad Sci USA 75 6 1978 2959
4. K. Andersen A. Gaafar A.M. El-Hassan Evaluation of the polymerase chain reaction in the diagnosis of cutaneous leishmaniasis due to Leishmania major : A comparison with direct microscopy of smears and sections from lesions Trans R Soc Trop Med Hyg 90 1996 133
5. R.L. Anthony M. Grogl J.B. Sacci Rapid detection of Leishmania amastigotes in fluid aspirates and biopsies of human tissues Am J Trop Med Hyg 37 2 1987 271
6. Armed Forces Pest Management Board Technical Information Memorandum No. 36, Defense Pest Management Information Analysis Center, WRAMC, Washington, DC, August,
7. N. Aronson J. Jackson A. Magill Sodium stibogluconate therapy for leishmaniasis: The experience of the American military 1989-1996 Acta Parasitologica Turcica 21 suppl 1 1997 177
8. N. Aronson G. Wortmann S. Johnson Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: Recent US military experience Clin Infect Dis 1998
9. R. Badaro D.R. Benson M. Eulalo rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis J Infect Dis 173 1996 758
10. W.R. Ballou J.B. McClain D.M. Gorden Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis Lancet 2 1987 13
11. P.A. Bates M. Gottlieb Dwyer Leishmania donovani : Identification of glycoproteins released by promastigotes during growth in vitro Exp Parasitol 67 1988 199
12. J.D. Berman Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years Clin Infect Dis 24 1997 684
13. J.D. Berman W.L. Hanson W.L. Chapron Antileishmanial activity of liposome encapsulated amphotericin B in hamsters and monkeys Antimicrob Agents Chemother 30 1986 847
14. J.M. Burns Jr W.G. Shreffler D.R. Benson Molecular characterization of a Kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis Proc Natl Acad Sci USA 90 2 1993 775
15. G. Caceres-Dittmar F.J. Tapia M.A. Sanchez Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction Clin Exp Immunol 91 1993 500
16. H.L. Callahan I.F. Portal S.J. Bensinger Leishmania spp.: Temperature sensitivity of promastigotes in vitro as a model for tropism in vivo Exp Parasitol 84 3 1996 400
17. H.L. Callahan A.C. Portal R. Devereaux An axenic amastigote system for drug screening Antimicrob Agents Chemother 41 4 1997 818
18. J.D. Chulay H.C. Spencer M. Mugambi ECG changes during treatment of leishmaniasis with pentavalent antimony Am J Trop Med Hyg 34 1985 702
19. D.H. Connor R. Neafie Cutaneous leishmaniasis C.H. Binford D.H. Connor Pathology of tropical and extraordinary diseases: An atlas vol 1 1976 Armed Forces Institute of Pathology Washington DC 262
20. J. Convit M. Ulrich C.T. Fernandez The clinical and immunological spectrum of American cutaneous leishmaniasis Trans R Soc Trop Med Hyg 87 1993 444
21. J.M. Costa M.N. Burattini A. Barral Diabetes mellitus associated with pentamidine isethionate in diffuse cutaneous leishmaniasis Rev Soc Bras Med Trop 28 4 1995 405
22. E.R. Cross W.W. Newcomb C.J. Tucker Use of weather data and remote sensing to predict the geographic and seasonal distribution of Phlebotomus papatasi in southwest Asia Am J Trop Med Hyg 54 5 1996 530
23. R.N. Davidson L. Di Martino L. Gradoni Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: A multi-center trial Quarterly Journal of Medicine 87 1994 75
24. P. del Giudice P. Marty J.P. Lacour Cutaneous leishmaniasis due to Leishmania infantum : Case reports and literature review Arch Dermatol 134 1998 193
25. R. Dietze S.M.S. Fagundes E.F. Brito Treatment of kala-azar in Brazil with Amphocil (amphotericin B cholesterol dispersion) for 5 days Trans R Soc Trop Med Hyg 89 1995 309
26. R. Dietze E.P. Milan J.D. Berman Treatment of Brazilian kala-azar with a short course of Amphocil (amphotericin B cholesterol dispersion) Clin Infect Dis 17 1993 981
27. D.C. Dillon C.H. Day J.A. Whittle Characterization of a Leishmania tropica antigen that detects immune responses in Desert Storm viscerotropic leishmaniasis patients Proc Natl Acad Sci USA 92 17 1995 7981
28. S.L. Ellis A.M. Shakanan D.M. Dwyer Kala-azar patients possess antibodies to the Leishmania donovani secretory acid phosphatase (abstract) Am J Trop Med Hyg 55 2 1997 572
29. Endy TP, King AD, Magill AJ, et al: Cytokine expression in patients with cutaneous leishmaniasis treated with sodium stibogluconate (Pentostam) therapy. (in preparation)
30. Endy TP, Larson KK, Magill AJ, et al: T-helper response in a patient with visceral leishmaniasis treated with sodium stibogluconate (Pentostam) therapy. (in preparation)
31. O. Fernandes M. Bozza Pascoale An oligonucleotide probe derived from kDNA mini-repeats is specific for Leishmania (Viannia) Mem Inst Oswaldo Cruz 91 1996 279
32. O. Fernandes V.K. Murthy U. Kurath Mini-exon gene in human pathogenic Leishmania species Mol Biochem Parasitol 66 1994 261
33. O. Fernandes C. Pirmez W. Degrave Molecular diagnosis of human American mucocutaneous leishmaniasis Acta Parasitologica Turcica 21 suppl 1 1997 90
34. E.D. Franke F.S. Wignall M.E. Cruz Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis Ann Intern Med 113 1990 934
35. D.J. Fryauff G.B. Modi N.S. Mansour Epidemiology of cutaneous leishmaniasis at a focus monitored by the multinational force and observers in the northeastern Sinai Desert of Egypt Am J Trop Med Hyg 49 5 1993 598
36. Gambel JM, Brundage JF, Burge RJ, et al: Survey of US Army soldiers' knowledge, attitudes, and practices (KAPa) regarding personal protection measures (PPMs) to prevent arthropod-related diseases and nuisance bites. Mil Med (in press)
37. Gambel JM, Brundage JF, Kuschner RA, et al: Deployed US Army soldiers' knowledge and use of personal protective measures (PPMs) to prevent arthropod-related casualties. J Travel Medicine (in press)
38. R.A. Gasser Jr A.J. Magill C.N. Oster Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis Clin Infect Dis 18 1994 83
39. M. Goihman-Yahr American mucocutaneous leishmaniasis Dermatol Clin 12 4 1994 703
40. L. Gradoni R. Pizzuti A. Scatone Recrudescence of visceral leishmaniasis unrelated to HIV infection in Campania region of Italy Trans R Soc Trop Med Hyg 90 1996 234
41. S.A. Gravelink E.A. Lerner Leishmaniasis Am Acad Derm 34 2 1996 257
42. M. Grogl J.L. Daugirda D.L. Hoover Survivability and infectivity of viscerotropic Leishmania tropica from Operation Desert Storm participants in human blood products maintained under blood bank conditions Am J Trop Med Hyg 49 3 1993 308
43. Grogl M, Gasser RA, Magill AJ, et al: Cutaneous leishmaniasis in US rangers and marines associated with jungle warfare training in French Guiana 1992-1993 (abstract #619). Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta, GA, November, 1993
44. M. Grogl A.M. Oduola L.D. Cordero Leishmania spp.: Development of Pentostam resistant clones in vitro by discontinuous drug exposure Exp Parasitol 69 1 1989 78
45. M. Grogl T.N. Thomasen E.D. Franke Drug-resistance in leishmaniasis: Its implications in systemic chemotherapy of cutaneous and mucocutaneous disease Am J Trop Med Hyg 47 1 1992 117
46. W.L. Hanson W.L. Chapman Jr V.B. Waits Development of Leishmania braziliensis lesions and relationship of numbers of amastigotes to lesion area on antimony-treated and untreated hamsters J Parasitol 77 1991 780
47. D.T. Hart Cutaneous and visceral leishmaniasis: A historical prospective Trans R Soc Trop Med Hyg 79 1985 740
48. B.L. Herwaldt J.D. Berman Recommendations for beating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies Am J Trop Med Hyg 46 1992 296
49. T. NG D. Harbecke M. Wiese Monoclonal antibodies directed against Leishmania secreted acid phosphatase and lipoposphoglycan: Partial characterization of private and public epitopes Eur J Biochem 217 1993 603
50. J.E. Jackson J.D. Tally W.Y. Ellis Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania spp. from patients unresponsive to pentavalent antimony therapy Am J Trop Med Hyg 43 5 1990 464
51. S.N. Jha N.K.P. Singh T.K. Jha Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial J Assoc Physicians India 39 1991 314
52. D.C. Kalter Cutaneous and mucocutaneous leishmaniasis Progress in Dermatology 23 1989 1
53. D.C. Kalter Laboratory tests for the diagnosis and evaluation of leishmaniasis Dermatol Clin 12 1 1994 37
54. J.H. Keeling Tropical parasitic infections Textbook of Military Medicine, Part III: Disease and the Environment, Military Dermatology 1994 Office of the Surgeon General Washington, DC
55. Kenner JR, Aronson NE, Bratthauer G, et al: Use of a monoclonal antibody to identify Leishmania parasites in formalin-fixed tissues. Journal of Cutaneous Pathology (in press)
56. Klotz F, Muturi M, Wasunna KM, et al: Serum nitric oxide levels in visceral and cutaneous leishmaniasis: Correlation with successful treatment. Poster Session: Host Defenses II: Immunology and Host Defenses, Bacterial Vaccines, Immunomodulators, and Immune Response. 37th ICAAC, Toronto, Ontario, Canada, 1997
57. R. Killick-Kendrick A.D.M. Bryceson W. Peters Zoonotic cutaneous leishmaniasis in Saudi Arabia: Lesions healing naturally in man followed by a second infection with the same zymodeme of Leishmania major Trans R Soc Trop Med Hyg 79 1985 363
58. R.D. Kreutzer H.A. Christensen Characterization of Leishmania species by isoenzyme electrophoresis Am J Trop Med Hyg 29 1980 199
59. R.D. Kreutzer A. Corredor G. Grimaldi Jr Characterization of Leishmania colombiensis spp. (kinetoplastida: trypanosomatidae), a new parasite infecting humans, animals, and phlebotomine sand flies in Colombia and Panama Am J Trop Med Hyg 44 6 1991 662
60. D. Kreutzer M. Grogl F.A. Neva Identification and genetic comparison of leishmanial parasites causing viscerotropic and cutaneous disease in soldiers returning from Operation Desert Storm Am J Trop Med Hyg 49 3 1993 357
61. R. Lainson On Leishmania enrietti and other enigmatic Leishmania species of the Neotropics Mem Inst Oswaldo Cruz 92 3 1997 337
62. R.P. Lane Sand flies (Phlebotominae) R.P. Lane R. Crossby Medical Insects and Arachnids 1993 Chapman and Hall London, UK
63. E.A. Llanos-Cuentas P.D. Marsden C.C. Cuba Possible risk factors in development of mucosal lesions in leishmaniasis [letter] Lancet 2 1984 295
64. A. Magill M. Grogl R. Gasser Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm N Engl J Med 328 1993 1383
65. A.J. Magill M. Grogl S.C. Johnson Visceral infection due to L. tropica in veterans of ODS who presented 2 years after leaving Saudi Arabia [letter] Clin Infect Dis 19 4 1994 805
66. P.D. Marsden Leishmaniasis Br Med J 300 1990 666
67. P.D. Marsden E.A. Llanos-Cuentas E.L. Lago Human mucocutaneous leishmaniasis in Tres Bracos, Bahia-Brazil. An area of Leishmania braziliensis braziliensis transmission. Mucosal disease presentation and initial evolution Rev Soc Bras Med Trop 17 1984 179
68. S.K. Martin E.B. Rowton L.W. Thuita-Harun Antibody response to experimental L. donovani and L. major infections in hamsters Acta Parasitologica Turcica 21 suppl 1 1997 42
69. Martin SK, Thuita-Harun L, Adoyo-Adoyo M, et al: A diagnostic ELISA for visceral leishmaniasis, based on an antigen from media conditioned by Leishmania donovani promastigotes. Ann Trop Med Parasitol (in press)
70. S.K. Martin L.W. Thuita-Harun M.K. Wasunna Serum levels of antibodies to L. donovani fall with treatment of kala-azar Acta Parasitologica Turcica 21 1997 24
71. A. McGregor WHO warns of epidemic of Leishmania Lancet 351 1998 575
72. P.C. Melby R.D. Kreutzer D. McMahon-Pratt Cutaneous leishmaniasis: Review of 59 cases seen at the National Institutes of Health Clin Infect Dis 15 1992 924
73. T.R. Navin F.E. Arana A.M. de Merida Cutaneous leishmaniasis in Guatemala: Comparison of diagnostic methods Am J Trop Med Hyg 42 1 1990 36
74. C.O. Okunji M.M. Iwu J.E. Jackson Biological activity of saponins from two Dracaena species Adv Exp Med Biol 404 1996 415
75. E. Oldfield M. Wallace E.C. Hyams Endemic infectious diseases of the Middle East Rev Infect Dis 13 suppl 3 1991 S199
76. C.N. Oster J.D. Chulay L.D. Hendricks American cutaneous leishmaniasis: A comparison of three sodium stibogluconate treatment schedules Am J Trop Med Hyg 34 5 1985 856
77. K.J. Ott W.L. Hanson L.A. Stauber Course of infection of Leishmania donovani in hamsters inoculated by the intraperitoneal route J Parasitol 53 3 1967 641
78. M.J. Perich A.L. Hoch N. Rizzo Insecticide barrier spraying for the control of sand fly vectors of cutaneous leishmaniasis in rural Guatemala Am J Trop Med Hyg 52 1995 485
79. W. Peters M.A. Al-Zahrani The leishmaniases–a public health problem in Saudi Arabia Saudi Medical Journal 8 4 1987 333
80. J.Q. Qu L. Zhong M. Masoom-Yasinzai Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinesin Trans R Soc Trop Med Hyg 88 5 1994 543
81. S.L. Reiner R.M. Locksley The regulation of immunity to leishmania major Annu Rev Immunol 13 1995 151
82. I.L. Robert M.J. Perich Phlebotomine sand fly (Diptera:Psychodidae) control using a residual pyrethroid insecticide J Am Mosq Control Assoc 11 1995 195
83. J.L. Sanchez B.M. Diniega J.W. Small Epidemiologic investigation of an outbreak of cutaneous leishmaniasis in a defined geographic focus of transmission Am J Trop Med Hyg 47 1 1992 47
84. J.J. Shaw Taxonomy of the genus Leishmania : Present and future trends and their implications Mem Inst Oswaldo Cruz 89 3 1994 471
85. S. Singh A. Gilman-Sachs K.P. Chang Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis J Parasitol 81 6 1995 1000
86. J. Soto P. Buffet M. Grogl Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine Am J Trop Med Hyg 50 1994 107
87. J. Soto F. Medina N. Dember Efficacy of permethrin-impregnated uniforms in the prevention of malaria and leishmaniasis in Colombian soldiers Clin Infect Dis 21 1995 599
88. J. Soto-Mancipe M. Grogl J.D. Berman Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia Clin Infect Dis 16 1993 417
89. S. Sundar H.W. Murray Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex J Infect Dis 173 1996 762
90. S. Sundar S.G. Reed S. Shanna Circulating T helper 1 (TH1) cell and TH2 cell-associated cytokines in Indian patients with visceral leishmaniasis Am J Trop Med Hyg 56 S 1997 522
91. S. Sundar S.G. Reed V.P. Singh Rapid, accurate and non-invasive field diagnosis of Indian visceral leishmaniasis: One half-drop of blood Acta Parasitologica Turcica 21 1997 105
92. S. Sundar F. Rosenkaimer H.W. Murray Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma J Infect Dis 170 1994 659
93. S. Sundar V.P. Singh H.W. Murray Current epidemic of visceral leishmaniasis in India Acta Parasitologica Turcica 21 1997 128
94. E.T. Takafuji L.D. Hendricks J.L. Daubek Cutaneous leishmaniasis associated with jungle training Am J Trop Med Hyg 29 4 1980 516
95. C.P. Thakur M. Kumar A.K. Pandey Comparison of regimens of treatment of antimony resistant kala-azar patients: A randomized study Am J Trop Med Hyg 45 1991 435
96. C.P. Thakur A.K. Pandey G.P. Dinha Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: A randomized dose finding study Trans R Soc Trop Med Hyg 90 1996 319
97. K.A. Weigle M. de Davalos P. Heredia Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: A comparison of seven methods Am J Trop Med Hyg 36 3 1987 489
98. WHO: Division of Control of Tropical Diseases. Statistics as of April, 1998.
99. G.W. Wortmann N.E. Aronson J. Byrd Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis Clin Infect Dis 27 1998 509
100. G. Wortmann S. Fraiser N.E. Aronson Failure of Amphotericin B lipid complex in treatment of cutaneous leishmaniasis Clin Infect Dis 26 1998 1006
101. J.T. Zajtchuk J.D. Casler E.M. Netto Mucosal leishmaniasis in Brazil Laryngoscope 99 1989 925